期刊文献+

乙酰左旋肉碱防治奥沙利铂引起的外周神经病变性疼痛的研究 被引量:1

Acetyl-L-carnitine prevents and reduces oxaliplation-evoked painful peripheral neuropathy
下载PDF
导出
摘要 目的:观察乙酰左旋肉碱(ALCAR)对奥沙利铂引起的外周神经病变性疼痛的防治效果。方法:选取SD雄性大鼠20只(150~200g),随机分为两组,ALCAR组与安慰剂组,每组各10只;用5%葡萄糖将奥沙利铂溶液稀释到2mg/mL,连续5d(d 0~d 4)腹腔注射2mg/kg。ALCAR(100mg/kg,p.o.)或对照液从0天开始注射(第1天注射奥沙利铂开始),并继续21d(即最后一次奥沙利铂注射后再持续15d)。并于d 0、d 8、d 15、d 22、d 29、d 35及d 41测定机械异常痛敏[4g von Frey hairs(VFH)]和机械痛敏(15g VFH)。结果:与对照组比较,ALCAR组大鼠在d 8、d 15、d 22、d 29、d 35及d 41机械异常痛敏(4g VFH)和机械痛敏明显改善(P<0.01)。结论:ALCAR可防治奥沙利铂引起的大鼠外周神经病变性疼痛。 To examine the potential efficacy of acetylLcarnitine (ALCAR) to prevent and treat,oxaliplationevoked pain. METHODS: 20 adult male Sprague-Dawley rats (150 200 g) were randomly divided into two groups, ALCAR group and control group. Each group had 10 rats. A stock solution of oxaliplatin is diluted to 2 mg/mL with 5%dextrose in distilled water and injected IP at 2 mg/kg on five consecutive days (d 0-d 4) in a volume of 1.0 mL/kg. AL CAR (100 mg/kg; p. o. ) or vehicle was given daily starting on day 0 (the day of the first oxaliplatin injection) and continuing until day 21 (i. e., 15 days after the last oxaliplatin injection. Mechanoallodynia and mechanohyperalgesia were assessed using von Frey hairs with bendingforces of 4 g and 15 g, respectively, on d 8, d 22, d27, d35, and d 41postoperatively. Withdrawal responses were counted and expressed as an overall percentage response. RESULTS:Mechanoallodynia (4 g) and mechanohyperalgesia (15 g) of the rats in ALCAR group were significantly and persistently reduced (P〈0.01) on d 8, d 22, d 27, d 35, and d 41 postoperatively in comparison with control group. CONCLUSION: It is concluded that ALCAR may be useful in the prevention and treatment of oxaliplatininduced painful peripheral neuropathy.
出处 《中国临床药理学与治疗学》 CAS CSCD 2011年第12期1379-1382,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 乙酰左旋肉碱 奥沙利铂 疼痛 AcetylLcarnitine Oxaliplation Pain
  • 相关文献

参考文献17

  • 1McWhinney SR, Goldberg RM, McLeod HL. Platinum neurotoxieity pharmacogenetics [ J ]. Mol Cancer Ther, 2009, 8(1):10--16. 被引量:1
  • 2Argyriou AA, Polychronopoulos P, Iconomou G, et al. A review on oxaliplatin-induced peripheral nerve damage[J]. Cancer Treat Rev, 2008, 34(4): 368-377. 被引量:1
  • 3Cersosimo RJ. Oxaliplatin-associated neuropathy: a review[J].Ann Pharmacother, 2005, 39 (1): 128 -135. 被引量:1
  • 4Leonard GD, Wright MA, Quinn MG, et al. Survey of oxaliplatin-associated neurotoxicity using an interview based questionnaire in patients with metastatic eolorectal cancer[J]. BMC Cancer, 2005, 5 (9): 116-126. 被引量:1
  • 5Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy[J].J Neurol, 2002, 249: 9-17. 被引量:1
  • 6Binder A, Stenge M, Maag R, et al. Pain in oxali platin-induced neuropathy-Sensitization in the peripheral and central nociceptive system[J]. Eur J Cancer, 2007, 43(18): 2658-2463. 被引量:1
  • 7De Grandis D. Acetyl-L carnitine for the treatment of chemotherapy induced peripheral neuropathy: a short review[J]. CNS Drugs, 2007, 21 Suppl 1: 39 --43, discussion 45--46. 被引量:1
  • 8Flattersa SJ, Xiao WH, Bennett GJ. Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy[J].Neurosci Lett, 2006, 397(3): 219-223. 被引量:1
  • 9Bennett GJ, Liu GK, Xiao WH, et al. Terminal ar bor degeneration-a novel lesion produced by the an tineoplastic agent paclitaxel [J].Eur J Neurosci 2011, 33(9): 1667--1676. 被引量:1
  • 10Pisano C, Pratesi G, I.accabue D, et al. Paclitaxel and cisplatin induced neurotoxicity: a protective role of acetyl-L-carnitine[J]. Clin Cancer Res, 2003, 9 (15) : 5756--5767. 被引量:1

同被引文献44

  • 1朱晓,邬晓敏,徐永萍.腺苷钴胺治疗奥沙利铂所致神经毒性的临床观察[J].实用癌症杂志,2014,29(3):355-356. 被引量:2
  • 2曹梦苒,华海清,秦叔逵.神经节苷脂预防奥沙利铂周围神经毒性的研究[J].肿瘤防治研究,2014,41(4):387-390. 被引量:21
  • 3何敬东,岳顺,陈小飞,贾正飞,刘扬清,潘池,朱锦绣,易竹筠.草酸铂神经毒性的防治[J].中国肿瘤临床与康复,2004,11(4):324-325. 被引量:19
  • 4徐德洲.B族维生素对60例奥沙利铂神经毒性预防的临床观察[J].青海医药杂志,2005,35(12):13-14. 被引量:6
  • 5Gamelin E, Gamelin L, Bossi L, et al. Clinical aspects and mo- lecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures [ J ]. Semin Oncol, 2002, 29 (5 Suppl 15 ) : 21-33. DOI : 10. 1053/sonc. 2002. 35525. 被引量:1
  • 6Argyriou AA, Cavaletti G, Briani C, et al. Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer [ J]. Cancer, 2013, 119 (2) : 438-444. DOI: 10. 1002/cncr. 27732. 被引量:1
  • 7Land SR, Kopec JA, Cecchini RS, et al. Neurotoxicity from ox- aliplatin combined with weekly bolus fluorouracil and leucovorin assurgical adjuvant chemotherapy for stage II and 111 colon canc- er: NSABP C-07[J]. J Clin Oncol, 2007, 25(16) : 2205-2211. DOI: 10. 1200/JCO. 2006.08. 6652. 被引量:1
  • 8Kidwell KM, Yothers G, Ganz PA, et al. Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adju- vant therapy for colon cancer: results from National Surgical Adju- vant Breast and Bowel Project trials C-07 and LTS-01 [J]. Can- cer, 2012, 118(22): 5614-5622. DOI: 10. 1002/cncr. 27593. 被引量:1
  • 9Lehky TJ, Leonard GD, Wilson RH, et al. Oxaliplatin-indueed neurotoxicity: acute hyperexcitability and chronic neuropathy [ J ]. Muscle Nerve, 2004, 29(3) : 387-392. DOI: 10. 1016/S0142- 1123 ( 00 ) 00079-7. 被引量:1
  • 10Krishnan AV, Goldstein D, Friedlander M, et al. Oxaliplatin-in- duced neurotoxicity and the development of neuropathy[J]. Mus- cle Nerve, 2005, 32(1 ): 51-60. DOI: 10. 1002/mus. 20340. 被引量:1

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部